Status:
COMPLETED
PTNS on Urinary and Global Quality of Life in MS Patients
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction
Conditions:
Multiple Sclerosis
Lower Urinary Tract Symptoms
Eligibility:
All Genders
18+ years
Brief Summary
This is a single-centered, prospective, longitudinal, observational cohort study of patients with MS who suffer from lower urinary tract symptoms (LUTS) and are refractory to two prior treatment modal...
Eligibility Criteria
Inclusion
- Diagnosis of Multiple Sclerosis
- Lower urinary tract symptoms (urinary frequency, urgency and/or incontinence)
- Failed prior first and second line therapy (behavioral and pharmacotherapy)
- Electing for Posterior Tibial Nerve Stimulation therapy for urinary symptoms
- Patients performing Intermittent Catheterization are Eligible
Exclusion
- Indwelling catheters (urethral or suprapubic)
- Currently pregnant or planning pregnancy
- Unable to attend weekly office visits for PTNS
- Urodynamic findings of bladder outlet obstruction
- History of:
- bladder reconstruction (augmentation cystoplasty, catheterizable channel) cystectomy bladder stones pacemaker or defibrillator malignancy of bladder sacral neuromodulation intravesical injection of onabotulinum toxin within 9 months
Key Trial Info
Start Date :
February 27 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 27 2022
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04063852
Start Date
February 27 2019
End Date
November 27 2022
Last Update
February 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109